HEALTHCARE SERVICES GROUP, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.85 USD | -1.36% |
|
-9.13% | +4.63% |
| Apr. 24 | Transcript : Healthcare Services Group, Inc., Q1 2024 Earnings Call, Apr 24, 2024 | |
| Apr. 24 | Earnings Flash (HCSG) HEALTHCARE SERVICES GROUP Posts Q1 Revenue $423.4M | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,803 | 2,091 | 1,326 | 889.1 | 765.8 | 799.1 | - | - |
| Enterprise Value (EV) 1 | 1,685 | 1,827 | 1,255 | 887.8 | 711.5 | 670.9 | 581.2 | 507.7 |
| P/E ratio | 28 x | 21.3 x | 29.2 x | 25.5 x | 19.9 x | 13 x | 12.5 x | 11 x |
| Yield | 3.28% | 2.91% | 4.71% | 7.13% | - | - | - | - |
| Capitalization / Revenue | 0.98 x | 1.19 x | 0.81 x | 0.53 x | 0.46 x | 0.47 x | 0.45 x | 0.45 x |
| EV / Revenue | 0.92 x | 1.04 x | 0.76 x | 0.53 x | 0.43 x | 0.39 x | 0.33 x | 0.29 x |
| EV / EBITDA | 13.1 x | 13.9 x | 14.1 x | 12.9 x | 6.88 x | 5.99 x | 4.97 x | 3.89 x |
| EV / FCF | 18.8 x | 8.58 x | 39.9 x | -66.4 x | - | 15.4 x | 6.95 x | - |
| FCF Yield | 5.31% | 11.7% | 2.5% | -1.51% | - | 6.51% | 14.4% | - |
| Price to Book | 3.93 x | 4.37 x | 2.9 x | 2.09 x | - | 1.52 x | 1.32 x | 1.22 x |
| Nbr of stocks (in thousands) | 74,119 | 74,424 | 74,539 | 74,088 | 73,849 | 73,646 | - | - |
| Reference price 2 | 24.32 | 28.10 | 17.79 | 12.00 | 10.37 | 10.85 | 10.85 | 10.85 |
| Announcement Date | 2/11/20 | 2/10/21 | 2/9/22 | 2/15/23 | 2/14/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,841 | 1,760 | 1,642 | 1,690 | 1,671 | 1,718 | 1,777 | 1,771 |
| EBITDA 1 | 128.3 | 131.5 | 89.28 | 68.81 | 103.5 | 111.9 | 117 | 130.6 |
| EBIT 1 | 114.4 | 117.2 | 74.62 | 53.5 | 47.97 | 75.53 | 80.46 | - |
| Operating Margin | 6.21% | 6.66% | 4.54% | 3.17% | 2.87% | 4.4% | 4.53% | - |
| Earnings before Tax (EBT) 1 | 85.1 | 129.2 | 61.82 | 45.08 | 53.06 | 84.44 | 86.58 | 98.39 |
| Net income 1 | 64.58 | 98.68 | 45.86 | 34.63 | 38.39 | 61.69 | 64.18 | 73.85 |
| Net margin | 3.51% | 5.61% | 2.79% | 2.05% | 2.3% | 3.59% | 3.61% | 4.17% |
| EPS 2 | 0.8700 | 1.320 | 0.6100 | 0.4700 | 0.5200 | 0.8320 | 0.8706 | 0.9846 |
| Free Cash Flow 1 | 89.41 | 212.9 | 31.42 | -13.38 | - | 43.7 | 83.6 | - |
| FCF margin | 4.86% | 12.09% | 1.91% | -0.79% | - | 2.54% | 4.7% | - |
| FCF Conversion (EBITDA) | 69.68% | 161.91% | 35.19% | - | - | 39.04% | 71.44% | - |
| FCF Conversion (Net income) | 138.45% | 215.72% | 68.51% | - | - | 70.83% | 130.27% | - |
| Dividend per Share 2 | 0.7975 | 0.8175 | 0.8375 | 0.8550 | - | - | - | - |
| Announcement Date | 2/11/20 | 2/10/21 | 2/9/22 | 2/15/23 | 2/14/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 420.4 | 426.8 | 424.9 | 414.5 | 424 | 417.2 | 418.9 | 411.4 | 423.8 | 423.4 | 425.8 | 432.3 | 438.4 | 437.9 | 439.7 |
| EBITDA 1 | 7.333 | 21.96 | 19.82 | 5.586 | 21.44 | 21.38 | 15.49 | 20.84 | 26.47 | 28.92 | 27.44 | 27.93 | 28.55 | 28.43 | 27.62 |
| EBIT 1 | 3.627 | 17.81 | 16.21 | 1.791 | 17.69 | 16.2 | 9.774 | -5.213 | 27.21 | 17.61 | 18.41 | 18.8 | 19.61 | 20.59 | 20.52 |
| Operating Margin | 0.86% | 4.17% | 3.81% | 0.43% | 4.17% | 3.88% | 2.33% | -1.27% | 6.42% | 4.16% | 4.32% | 4.35% | 4.47% | 4.7% | 4.67% |
| Earnings before Tax (EBT) 1 | 1.687 | 15.78 | 8.25 | 0.993 | 20.06 | 17.56 | 11.41 | -6.951 | 31.04 | 21.31 | 20.26 | 20.91 | 21.43 | 21.75 | 20.97 |
| Net income 1 | 2.105 | 11.33 | 6.82 | 0.322 | 16.16 | 12.68 | 8.598 | -5.494 | 22.6 | 15.31 | 14.82 | 15.21 | 15.76 | 16.17 | 15.6 |
| Net margin | 0.5% | 2.65% | 1.61% | 0.08% | 3.81% | 3.04% | 2.05% | -1.34% | 5.33% | 3.62% | 3.48% | 3.52% | 3.59% | 3.69% | 3.55% |
| EPS 2 | 0.0300 | 0.1500 | 0.0900 | - | 0.2200 | 0.1700 | 0.1200 | -0.0700 | 0.3100 | 0.2100 | 0.1995 | 0.2025 | 0.2085 | 0.2188 | 0.2110 |
| Dividend per Share 2 | 0.2112 | 0.2125 | 0.2138 | 0.2138 | 0.2150 | 0.2100 | - | - | - | - | - | - | - | - | - |
| Announcement Date | 2/9/22 | 4/20/22 | 7/20/22 | 10/19/22 | 2/15/23 | 4/26/23 | 7/26/23 | 10/25/23 | 2/14/24 | 4/24/24 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 118 | 264 | 70.8 | 1.28 | 54.3 | 128 | 218 | 291 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 89.4 | 213 | 31.4 | -13.4 | - | 43.7 | 83.6 | - |
| ROE (net income / shareholders' equity) | 14.3% | 21% | 9.83% | 7.88% | 8.78% | 12.9% | 11.5% | 11.8% |
| ROA (Net income/ Total Assets) | 9.13% | 13.1% | 5.87% | - | - | - | - | - |
| Assets 1 | 707.6 | 753.8 | 781.3 | - | - | - | - | - |
| Book Value Per Share 2 | 6.190 | 6.430 | 6.140 | 5.750 | - | 7.150 | 8.210 | 8.900 |
| Cash Flow per Share | 1.250 | 2.900 | 0.5000 | -0.1100 | - | - | - | - |
| Capex 1 | 4.37 | 4.34 | 5.69 | 5.21 | - | 5.6 | 6.31 | 7.08 |
| Capex / Sales | 0.24% | 0.25% | 0.35% | 0.31% | - | 0.33% | 0.36% | 0.4% |
| Announcement Date | 2/11/20 | 2/10/21 | 2/9/22 | 2/15/23 | 2/14/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
10.85
USD
Average target price
14.5
USD
Spread / Average Target
+33.64%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +4.63% | 798M | |
| +2.79% | 645M | |
| +14.52% | 416M |
- Stock Market
- Equities
- HCSG Stock
- Financials Healthcare Services Group, Inc.
